FDA announces plan to cut drug review times significantly

Chrissy Buteas President and Chief Executive Officer - HealthCare Institute of New Jersey
Chrissy Buteas President and Chief Executive Officer - HealthCare Institute of New Jersey
0Comments

On June 17, the Food and Drug Administration announced a new national priority voucher plan. This initiative aims to reduce drug review times from the current average of 10 to 12 months to just one to two months.

Chrissy Buteas, president and chief executive officer of the HealthCare Institute of New Jersey, responded positively to this development on June 19. She stated, “Anything that can shorten a review period without compromising safety and efficacy means patients will benefit from new discoveries even sooner.”



Related

Lori Roth, CPA/ABV, CFF, NJBIA Board Chairperson, Global Managing Partner, Prager Metis

Amazon general manager describes leadership approach for 3,000-person workforce in New Jersey

Alessandro Carbone oversees Amazon’s ACY1 facility in southern New Jersey as its general manager overseeing 3,000 employees. He shared insights about leadership strategies focused on trust-building and empowerment during an interview on Learn and Be Curious with Doug Herrington.

Michele Siekerka President & CEO

Experts debate consumer impact of New Jersey’s proposed Climate Superfund Act

New Jersey lawmakers heard conflicting views over whether a proposed $50 billion penalty on fossil fuel companies would raise consumer prices. Economists debated if such retroactive charges could impact gas prices or harm middle-class investors through pension holdings.

Michele Siekerka President & CEO

Peapack Capital appoints Michael Mehosky as senior managing director and national sales manager

Michael Mehosky has been appointed Senior Managing Director at Peapack Capital. In this role he will lead national sales strategy for the equipment finance subsidiary as it aims for significant growth over the next year-and-a-half.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from New Jersey Review.